Patient Education
- Desiree Losell
- Jul 4
- 3 min read
Updated: 3 days ago
Hyperbaric Oxygen Therapy (HBOT)
Pulsed Electromagnetic Fields (PEMF) Therapy
Pulsed Electromagnetic Fields (PEMF)—Physiological Response and Its Potential in Trauma Treatment
A review in the International journal of molecular sciences gives a birds-eye view of the vast landscape of studies that have been published on PEMF, presenting the reader with a scaffolded summary of relevant literature starting from categorical literature reviews down to individual studies for future research studies and clinical use.
Flatscher, J., Pavez Loriè, E., Mittermayr, R., Meznik, P., Slezak, P., Redl, H., & Slezak, C. (2023). Pulsed Electromagnetic Fields (PEMF)-Physiological Response and Its Potential in Trauma Treatment. International journal of molecular sciences, 24(14), 11239. https://doi.org/10.3390/ijms241411239 (https://pmc.ncbi.nlm.nih.gov/articles/PMC10379303/)
A randomized, double-blind, placebo-controlled clinical trial using a low-frequency magnetic field in the treatment of musculoskeletal chronic pain
In a randomized, double-blind, sham-controlled clinical trial, patients with either chronic generalized pain from fibromyalgia (FM) or chronic localized musculoskeletal or inflammatory pain were exposed to a PEMF (400 μT) through a portable device fitted to their head during twice-daily 40 min treatments over seven days.
Thomas, A. W., Graham, K., Prato, F. S., McKay, J., Forster, P. M., Moulin, D. E., & Chari, S. (2007). A randomized, double-blind, placebo-controlled clinical trial using a low-frequency magnetic field in the treatment of musculoskeletal chronic pain. Pain research & management, 12(4), 249–258. https://doi.org/10.1155/2007/626072 (https://pmc.ncbi.nlm.nih.gov/articles/PMC2670735/)
Efficacy and safety of the pulsed electromagnetic field in osteoarthritis: a meta-analysis
This study in BMJ Open investigates the efficacy and safety of the pulsed electromagnetic field (PEMF) therapy in treating osteoarthritis (OA).
Wu Z, Ding X, Lei G, et al. Efficacy and safety of the pulsed electromagnetic field in osteoarthritis: a meta-analysis. BMJ Open. 2018;8:e022879. doi: 10.1136/bmjopen-2018-022879 (https://bmjopen.bmj.com/content/8/12/e022879)
Extracorporeal Blood Oxygenation and Ozonation (EBOO)
OZONE & UBI
Medical Weight Loss
Chelation (EDTA)
A review in the The Cochrane database of systematic reviews explores Chelation therapy as a form of alternative medicine in the treatment of atherosclerotic cardiovascular disease.
Villarruz-Sulit, M. V., Forster, R., Dans, A. L., Tan, F. N., & Sulit, D. V. (2020). Chelation therapy for atherosclerotic cardiovascular disease. The Cochrane database of systematic reviews, 5(5), CD002785. https://doi.org/10.1002/14651858.CD002785.pub2 (https://pubmed.ncbi.nlm.nih.gov/32367513/)
High dose vitamin C (HDVC)
Examining the evidence for the use of vitamin C in the prophylaxis and treatment of the common cold
An article in the Journal of the American Academy of Nurse Practitioners presents a critical evaluation of the current evidence concerning the therapeutic value of vitamin C for the prophylaxis and treatment of the common cold.
Heimer, K. A., Hart, A. M., Martin, L. G., & Rubio-Wallace, S. (2009). Examining the evidence for the use of vitamin C in the prophylaxis and treatment of the common cold. Journal of the American Academy of Nurse Practitioners, 21(5), 295–300. https://doi.org/10.1111/j.1745-7599.2009.00409.x (https://pubmed.ncbi.nlm.nih.gov/19432914/)
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer
A review in the Journal of experimental & clinical cancer research provides an elaborate overview of pre-clinical and clinical studies using high-dose IVC as anti-cancer agent, as well as a detailed evaluation of the main known molecular mechanisms involved. In addition, an outlook on future implications of high-dose vitamin C in cancer treatment is presented and recommendations for further research are discussed.
Böttger, F., Vallés-Martí, A., Cahn, L., & Jimenez, C. R. (2021). High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer. Journal of experimental & clinical cancer research : CR, 40(1), 343. https://doi.org/10.1186/s13046-021-02134-y (https://pubmed.ncbi.nlm.nih.gov/34717701/)
High-dose vitamin C enhances cancer immunotherapy
A study in Science translational medicine shows that a fully competent immune system is required to maximize the antiproliferative effect of VitC in breast, colorectal, melanoma, and pancreatic murine tumors. High-dose VitC modulates infiltration of the tumor microenvironment by cells of the immune system and delays cancer growth in a T cell-dependent manner.
Magrì, A., Germano, G., Lorenzato, A., Lamba, S., Chilà, R., Montone, M., Amodio, V., Ceruti, T., Sassi, F., Arena, S., Abrignani, S., D'Incalci, M., Zucchetti, M., Di Nicolantonio, F., & Bardelli, A. (2020). High-dose vitamin C enhances cancer immunotherapy. Science translational medicine, 12(532), eaay8707. https://doi.org/10.1126/scitranslmed.aay8707 (https://pubmed.ncbi.nlm.nih.gov/32102933/)
Intravenously administered vitamin C as cancer therapy: three cases
A case report in the Canadian Medical Association journal = journal de l'Association medicale canadienne found 3 well-documented cases of advanced cancers, confirmed by histopathologic review, where patients had unexpectedly long survival times after receiving high-dose intravenous vitamin C therapy. The report examines clinical details of each case in accordance with National Cancer Institute (NCI) Best Case Series guidelines.
Padayatty, S. J., Riordan, H. D., Hewitt, S. M., Katz, A., Hoffer, L. J., & Levine, M. (2006). Intravenously administered vitamin C as cancer therapy: three cases. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 174(7), 937–942. https://doi.org/10.1503/cmaj.050346 (https://pubmed.ncbi.nlm.nih.gov/16567755/)
Comments